首页> 外国专利> BENCIMIDAZOLINONAS, BENZOXAZOLINONAS, BENZOPIPERAZINONAS, INDANONAS AND THEIR DERIVATIVES AS INHIBITORS OF THE XA FACTOR.

BENCIMIDAZOLINONAS, BENZOXAZOLINONAS, BENZOPIPERAZINONAS, INDANONAS AND THEIR DERIVATIVES AS INHIBITORS OF THE XA FACTOR.

机译:苯并咪唑类,苯并恶唑类,苯并哌嗪类,靛蓝属及其衍生物是XA因子的抑制剂。

摘要

A compound of formula I: ** (formula) ** or a stereoisomer or pharmaceutically acceptable salt thereof, wherein: one of the W, W1, W2 and W3 is C-D and the remaining are C-R1; alternatively, W-W1, W1-W2 or W2-W3 combine to form C (Da) N and the remaining ones are C-R1; D is selected from CN, C (= NR7) NR8R9, NHC ((= NR7) NR8R9, NR8CH (= NR7), C (O) NR8R9 and (CH2) t NR8R9; Da is NH2, NH (C1_3 alkyl), N (C1_3 alkyl) 2 or C1_3 alkoxy; J is selected from N (ZAB) and CR (ZAB); and Ja and Jb together are selected from CONHCReRf, SO2NHCReRf, (CRaRb) qSO2NRd and (CRaRb) bCOCO (CReRf) c, in those that b + c = 0 or 1; alternatively, J and Ja together are selected from CON (ZAB) (CRcRb) q and N (ZAB) Q (RcRb) a; and Jb is selected from NRd, O and CReRf; Q is CO or CS; alternatively, J, Ja and Jb together are selected from CR (ZAB) (CRaRb) aQNRd, CR (ZAB) (CRaRb) dC (O) O, CR (ZAB) NHCOCReRf, CR (ZAB) NHSO2CReRf, N (ZAB) (CRaRb) aQNRd, N (ZAB) (CRaRb) C (O) O, N (ZAB) SO2) (CRcRb) aCReRf; N (Z-A-B) SO2 (CRcRb) aNRd, CON (Z-A-B) CReRf; CONRb (CRcRb) aN (ZAB) and ** (formula) ** R is selected from H, C1-6 alkyl, NH2, NH (C1-6 alkyl), N (C1-6 alkyl) 2, OH, C1 alkoxy -66, C1-6 alkoxyC1-4alkyl, (CH2) tNR8R9, 5 or 6 membered aromatic heterocyclyl-C1-4alkyl and C1-4alkyl, in which the aromatic heterocyclyl and aryl groups are substituted with 0-1 R4; Ra is selected from H, C16 alkyl, C (O) R2b, 5- or 6-membered aromatic heterocyclyl-C1-4 alkyl and C1-4 arylalkyl, in which the aromatic heterocyclyl and aryl groups are substituted with 0-1 R4 ; Rb is H or C1-2 alkyl; Rc is selected from H, C1-6 alkyl, C (O) R2b, S (O) pR2b, BO2H2, 5- or 6-membered aromatic heterocyclyl, C1-4 alkyl and aryl-C1-4 alkyl, in which the aromatic heterocyclyl groups and aryl are substituted with 0-1 R4; Rd is selected from H, OH, NH2, C1-2 alkyl and C1-2-alkyl, '' alternatively, Rc and Rd, when attached to adjacent atoms, together form a double bond; Re is selected from H, OH, NH2, C1-2 alkyl and C1-2-alkyl, '' alternatively, Rc and Re, when attached to adjacent atoms, together form a double bond.
机译:式I的化合物:**(式)**或其立体异构体或药学上可接受的盐,其中:W,W1,W2和W3中的一个为C-D,其余为C-R1;或者,W-W1,W1-W2或W2-W3结合形成C(Da)N,其余为C-R1。 D选自CN,C(= NR7)NR8R9,NHC((= NR7)NR8R9,NR8CH(= NR7),C(O)NR8R9和(CH2) (C 1-3烷基)2或C 1-3烷氧基; J选自N(ZAB)和CR(ZAB); Ja和Jb一起选自CONHCReRf,SO2NHCReRf,(CRaRb)qSO2NRd和(CRaRb)bCOCO(CReRf)c b + c = 0或1的那些;或者,J和Ja一起选自CON(ZAB)(CRcRb)q和N(ZAB)Q(RcRb)a;并且Jb选自NRd,O和CReRf; Q是CO或CS;或者J,Ja和Jb一起选自CR(ZAB)(CRaRb)aQNRd,CR(ZAB)(CRaRb)dC(O)O,CR(ZAB)NHCOCReRf,CR(ZAB)NHSO2CReRf, N(ZAB)(CRaRb)aQNRd,N(ZAB)(CRaRb)C(O)O,N(ZAB)SO2)(CRcRb)aCReRf; N(Z-A-B)SO2(CRcRb)aNRd,CON(Z-A-B)CReRf; CONRb(CRcRb)aN(ZAB)和**(分子式)** R选自H,C1-6烷基,NH2,NH(C1-6烷基),N(C1-6烷基)2,OH,C1烷氧基-66,C1-6烷氧基C1-4烷基,(CH2)tNR8R9、5或6元芳族杂环基-C1-4烷基和C1-4烷基,其中芳族杂环基和芳基被0-1个R4取代; Ra选自H,C16烷基,C(O)R2b,5-或6-元芳族杂环基-C1-4烷基和C1-4芳基烷基,其中芳族杂环基和芳基被0-1个R4取代; Rb是H或C1-2烷基; Rc选自H,C1-6烷基,C(O)R2b,S(O)pR2b,BO2H2、5-或6-元芳族杂环基,C1-4烷基和芳基-C1-4烷基,其中芳族杂环基和芳基被0-1个R4取代; Rd选自H,OH,NH 2,C 1-2烷基和C 1-2烷基,''或者,R c和R d,当连接至相邻原子时,一起形成双键; Re选自H,OH,NH 2,C 1-2烷基和C 1-2烷基,''或者,R c和R e在连接至相邻原子时一起形成双键。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号